Absolute risk of cardiovascular disease and lipid management targets

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 9, 2013, Pages 689-697

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ishibashi, Shun ^a   Birou, Sadatoshi ^a   Daida, Hiroyuki ^a   Dohi, Seitaro ^a   Egusa, Genshi ^a   Hiro, Takafumi ^a   Hirobe, Kazuhiko ^a   Iida, Mami ^a   Kihara, Shinji ^a   Kinoshita, Makoto ^a   Maruyama, Chizuko ^a   Ohta, Takao ^a   Okamura, Tomonori ^a   Yamashita, Shizuya ^a   Yokode, Masayuki ^a   Yokote, Koutaro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; JAPAN; LIFESTYLE MODIFICATION; PATIENT CARE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; CARDIOLOGY; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISEASE MANAGEMENT; DYSLIPIDEMIAS; FEMALE; HUMANS; JAPAN; LIPIDS; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 84884564450     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.17392     Document Type: Article

References (31)

1. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 2008; 117: 743-753
2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group: Estimation of tenyear risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003; 24: 987-1003
3. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1087-1095
4. Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H; Japan Arteriosclerosis Longitudinal Study Group: Serum total and no high-density lipoprotein cholesterol and the risk prediction of cardiovascular events-the JALS-ECC-. Circ J, 2010; 74: 1346-1356
5. NIPPON DATA80 Research Group: Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J, 2006; 70: 1249-1255
6. Arima H, Yonemoto K, Doi Y, Ninomiya T, Hata J, Tanizaki Y, Fukuhara M, Matsumura K, Iida M, Kiyohara Y: Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study. Hypertens Res, 2009; 32: 1119-1122
7. Matsumoto M, Ishikawa S, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E: Risk charts illustrating the 10-year risk of myocardial infarction among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol, 2009; 19: 94-100
8. Ishikawa S, Matsumoto M, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E: Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol, 2009; 19: 101-106
9. Noda H, Iso H, Sairenchi T, Irie F, Fukasawa N, Toriyama Y, Ota H, Nose T: Prediction of stroke, coronary heart disease, cardiovascular disease, cancer, and total death based on results of annual health checkups. Japanese Journal of Public Health, 2006; 53: 265-276
10. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Lowdensity lipoprotein cholesterol and non-high density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study. Atherosclerosis, 2009; 203: 587-592
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
12. Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis, 2011; 217(Suppl 1): S1-S44
13. Okayama A, Kadowaki T, Okamura T, Hayakawa T, Ueshima H; NIPPON DATA80 Research Group: Agespecific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens, 2006; 24: 459-462
14. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, Okamura T, Minowa M, Iimura O: Cigarette smoking as a risk factor for stroke death in Japan, NIPPON DATA80. Stroke, 2004; 35: 1836-1841
15. Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, Nakamura K, Saitoh S, Nakamura Y, Hayakawa T, Kita Y, Okayama A, Ueshima H: Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80. Diabetologia, 2008; 51: 575-582
16. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H; NIPPONDATA80 Research Group: The relationship between serum total cholesterol and all-cause or causespecific mortality in a 17. 3-year study of a Japanese cohort. Atherosclerosis, 2007; 190: 216-223
17. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M: Chronic kidney disease and cardiovascular disease in general Japanese population: the Hisayama Study. Kidney Int, 2005; 68: 228-236
18. Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H: Impact of kidney disease and blood pressure on the development of cardiovascular disease: An overview from the Japan Arteriosclerosis Longitudinal Study. Circulation, 2008; 118: 2694-2701
19. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y: Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population-the Ohasama study. Nephrol Dial Transplant, 2007; 22: 1910-1915
20. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Ohnishi H, Saitoh S, Sakata K, Okayama A, Ueshima H; NIPPON DATA90 Research Group: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: Nippon Data 90. Circ J, 2006; 70: 954-959
21. Kokubo Y, Nakamura S, Okamura T, Yoshimasa Y, Makino H, Watanabe M, Higashiyama A, Kamide K, Kawanishi K, Okayama A, Kawano Y: Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke, 2009; 40: 2674-2679
22. Fager G, Wiklund O: Cholesterol reduction and clinical benefit. Are there limits to our expectations? Arterioscler Thromb Vasc Biol, 1997; 17: 3527-3533
23. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet, 2005 366: 1267-1278
24. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1096-1100
25. Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, Sakaino N, Kitagawa A; Multicenter Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in Patients With Acute Myocardial Infarction Investigators: Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol, 2006; 97: 1165-1171
26. Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H: Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb, 2011; 18: 454-463
27. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Yoshimasa Y, Okayama A: Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis, 2010; 209: 290-294
28. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Ohta H: Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study. J Atheroscler Thromb, 2010; 17: 30-36
29. Sasaki J, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Itakura H, Hishida H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y; JELIS Investigators: Relationship between coronary artery disease and non HDL-C, and effect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins: sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS). J Atheroscler Thromb, 2012; 19: 194-204
30. Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N: Proposed guidelines for hypertriglyceridemia in Japan with non HDL-Cholesterol as the second target. J Atheroscler Thromb, 2008; 15: 116-121
31. Sugimoto K, Isobe K, Kawakami Y, Yamada N: The relationship between non HDL-Cholesterol and other lipid parameters in Japanese subjects. J Atheroscler Thromb, 2005; 12: 107-110